Cardiology

Stem cells fail to alleviate peripheral artery disease

A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.

Cardiology

AHA: Ticagrelor not shown to be superior to clopidogrel in PAD

(HealthDay)—Ticagrelor is not superior to clopidogrel for reduction of cardiovascular events in patients with peripheral artery disease, according to a study published online Nov. 13 in the New England Journal of Medicine ...

Surgery

Post-CABG risk of death increased for blacks with PAD

(HealthDay)—For patients undergoing coronary artery bypass grafting (CABG), the risk of death is higher for those with peripheral artery disease (PAD), particularly for black versus white patients, according to a study ...

page 22 from 29